United States (US) Generic Pharmaceutical Market (2025-2031) | Forecast, Industry, Value, Companies, Competitive Landscape, Growth, Outlook, Share, Analysis, Size & Revenue, Segmentation, Trends

Name: United States (US) Generic Pharmaceutical Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (Simple Generics, Specialty Generics, Biosimilars), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others) And Competitive Landscape

Product Code: ETC9966869	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Generic Pharmaceutical Market Outlook
Market Size of United States (US) Generic Pharmaceutical Market, 2024
Forecast of United States (US) Generic Pharmaceutical Market, 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Revenues & Volume for the Period 2021- 2031
United States (US) Generic Pharmaceutical Market Trend Evolution
United States (US) Generic Pharmaceutical Market Drivers and Challenges
United States (US) Generic Pharmaceutical Price Trends
United States (US) Generic Pharmaceutical Porter's Five Forces
United States (US) Generic Pharmaceutical Industry Life Cycle
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Simple Generics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Specialty Generics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Biosimilars for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Central Nervous System Disorders for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Respiratory Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Hormones & Related Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Gastrointestinal Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Cardiovascular Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Small Molecule for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Large Molecule for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Oral for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Injectable for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Inhalable for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Generic Pharmaceutical Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Generic Pharmaceutical Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Application
Market Opportunity Assessment By Product
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By Distribution Channel
United States (US) Generic Pharmaceutical Top Companies Market Share
United States (US) Generic Pharmaceutical Competitive Benchmarking By Technical and Operational Parameters
United States (US) Generic Pharmaceutical Company Profiles
United States (US) Generic Pharmaceutical Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Generic Pharmaceutical Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Generic Pharmaceutical Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Generic Pharmaceutical Market - Industry Life Cycle

3.4 United States (US) Generic Pharmaceutical Market - Porter's Five Forces

3.5 United States (US) Generic Pharmaceutical Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Generic Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) Generic Pharmaceutical Market Revenues & Volume Share, By Product, 2021 & 2031F

3.8 United States (US) Generic Pharmaceutical Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 United States (US) Generic Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Generic Pharmaceutical Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases leading to higher demand for affordable medications

4.2.2 Rising healthcare costs driving the shift towards generic drugs

4.2.3 Patent expirations of major branded drugs creating opportunities for generic pharmaceutical companies

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for generic drug approvals leading to longer time to market

4.3.2 Intense competition among generic pharmaceutical companies leading to pricing pressures

4.3.3 Impact of trade policies and tariffs on raw material costs affecting profit margins

5 United States (US) Generic Pharmaceutical Market Trends

6 United States (US) Generic Pharmaceutical Market, By Types

6.1 United States (US) Generic Pharmaceutical Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Simple Generics, 2021- 2031F

6.1.4 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Specialty Generics, 2021- 2031F

6.1.5 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Biosimilars, 2021- 2031F

6.2 United States (US) Generic Pharmaceutical Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Central Nervous System Disorders, 2021- 2031F

6.2.3 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F

6.2.4 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Hormones & Related Diseases, 2021- 2031F

6.2.5 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Gastrointestinal Diseases, 2021- 2031F

6.2.6 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F

6.2.7 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3 United States (US) Generic Pharmaceutical Market, By Product

6.3.1 Overview and Analysis

6.3.2 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Small Molecule, 2021- 2031F

6.3.3 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Large Molecule, 2021- 2031F

6.4 United States (US) Generic Pharmaceutical Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Oral, 2021- 2031F

6.4.3 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Injectable, 2021- 2031F

6.4.4 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Inhalable, 2021- 2031F

6.4.5 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Generic Pharmaceutical Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.5.3 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.5.4 United States (US) Generic Pharmaceutical Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Generic Pharmaceutical Market Import-Export Trade Statistics

7.1 United States (US) Generic Pharmaceutical Market Export to Major Countries

7.2 United States (US) Generic Pharmaceutical Market Imports from Major Countries

8 United States (US) Generic Pharmaceutical Market Key Performance Indicators

8.1 Percentage of generic drug prescriptions filled compared to branded drugs

8.2 Average cost savings percentage for patients switching from branded to generic drugs

8.3 Number of ANDA (Abbreviated New Drug Application) approvals granted by the FDA

8.4 Research and development investment in developing generic versions of high-demand drugs

8.5 Percentage of market share held by top generic pharmaceutical companies

9 United States (US) Generic Pharmaceutical Market - Opportunity Assessment

9.1 United States (US) Generic Pharmaceutical Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Generic Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) Generic Pharmaceutical Market Opportunity Assessment, By Product, 2021 & 2031F

9.4 United States (US) Generic Pharmaceutical Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 United States (US) Generic Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Generic Pharmaceutical Market - Competitive Landscape

10.1 United States (US) Generic Pharmaceutical Market Revenue Share, By Companies, 2024

10.2 United States (US) Generic Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Generic Pharmaceutical Market

Estonia Generic Pharmaceutical Market

Ethiopia Generic Pharmaceutical Market

Fiji Generic Pharmaceutical Market

Finland Generic Pharmaceutical Market

Gabon Generic Pharmaceutical Market

Global Generic Pharmaceutical Market

Middle East Generic Pharmaceutical Market

North America Generic Pharmaceutical Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here